UBS Group’s Biofrontera AG American Depositary Shares BFRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-730
| Closed | -$2K | – | 11516 |
|
|
2021
Q4 | $2K | Sell |
730
-1,359
| -65% | -$6.11K | ﹤0.01% | 9934 |
|
|
2021
Q3 | $11K | Buy |
2,089
+171
| +9% | +$1.01K | ﹤0.01% | 7963 |
|
|
2021
Q2 | $12K | Sell |
1,918
-730
| -28% | -$4.45K | ﹤0.01% | 7936 |
|
|
2021
Q1 | $14K | Buy |
2,648
+2,599
| +5,304% | +$18.5K | ﹤0.01% | 7705 |
|
|
2020
Q4 | $0 | Sell |
49
-150
| -75% | -$1.07K | ﹤0.01% | 8978 |
|
|
2020
Q3 | $2K | Sell |
199
-103
| -34% | -$984 | ﹤0.01% | 7727 |
|
|
2020
Q2 | $2K | Buy |
302
+248
| +459% | +$1.59K | ﹤0.01% | 7700 |
|
|
2020
Q1 | $0 | Sell |
54
-146
| -73% | -$1.51K | ﹤0.01% | 8620 |
|
|
2019
Q4 | $2K | Buy |
+200
| New | +$2.13K | ﹤0.01% | 7892 |
|
|
2019
Q2 | – | Sell |
-871
| Closed | -$11K | – | 8314 |
|
|
2019
Q1 | $11K | Sell |
871
-625
| -42% | -$7.88K | ﹤0.01% | 6778 |
|
|
2018
Q4 | $18K | Buy |
1,496
+480
| +47% | +$6.07K | ﹤0.01% | 6889 |
|
|
2018
Q3 | $14K | Buy |
1,016
+160
| +19% | +$2.17K | ﹤0.01% | 7016 |
|
|
2018
Q2 | $10K | Buy |
+856
| New | +$11.6K | ﹤0.01% | 7156 |
|
UBS Group's BFRA Position: Q1 2022 in Review
UBS Group sold out of Biofrontera AG American Depositary Shares (BFRA) in Q1 2022, closing a stake of 730 shares — an estimated $2K sold.
UBS Group first reported a position in BFRA in Q2 2018 and held it in 13 quarters. The position peaked at $18K in Q4 2018. 0 funds tracked by Wall St. Rank hold BFRA as of Q1 2022.
- UBS Group reported no remaining Biofrontera AG American Depositary Shares position as of Q1 2022 after selling out during the quarter.
- UBS Group sold 730 Biofrontera AG American Depositary Shares shares in Q1 2022, an estimated $2K.
- UBS Group first reported a position in Biofrontera AG American Depositary Shares in Q2 2018 and held it in 13 quarters.
- UBS Group's Biofrontera AG American Depositary Shares position peaked at $18K in Q4 2018.
- 0 funds tracked by Wall St. Rank held Biofrontera AG American Depositary Shares as of Q1 2022.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.